InvestSMART

Colonial Wellington Global Health & Biotech - Managed Fund

Fund Objective
To provide long-term capital growth by predominantly investing in companies around the world; whose primary business is in the fields of pharmaceuticals; biotechnology; healthcare services and medical products. The option aims to outperform the MSCI All Country Health Care Index over rolling three-year periods before fees and taxes.
Fund Strategy
The option's strategy is to add value by investing; over the medium to long term; in quality companies; with sustainable earnings per share growth and sensible valuations; whose primary business is healthcare related. The option does not hedge currency risk.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
grow your money
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns.
Free Fees Report
investing
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers.
Free investor guide
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns. Free Fees Report
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers. Free investor guide

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return 6.96% 12.17% 5.08% -0.34% 7.02% 4.17% 5.84% 7.22%
Growth return 6.96% 12.17% 4.8% -0.6% -% 4.08% 5.78% 7.19%
Income return 0% 0% 0.28% 0.26% -% 0.09% 0.06% 0.03%
Market index (MSCI World Ex Australia NR AUD)
Total return 3.32% 6.34% 18.35% 22.32% 25.76% 20.9% 17.3% 12.82%
As at 31 Oct 2025. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Colonial Wellington Global Health & Biotech
International Equities
95.68%
Cash
4.32%
Australian Equities
0%
Property & Infrastructure
0%
Fixed Interest
0%
Alternatives
0%
Average Allocation of Peers
International Equities
94.83%
Cash
1.93%
Australian Equities
1.96%
Property & Infrastructure
1.16%
Fixed Interest
0%
Alternatives
0.12%

General Information

Fund Details
Type Description
Colonial Wellington Global Health & Biotech
Colonial First State Investments Limited
FSF0146AU
Equity World Other
Not Rated
Investment Fund
14 Apr 2000
$10.84 million (as at 30 Sep 2025)
$5.3933 (as at 5 Nov 2025)
$5.3879 (as at 5 Nov 2025)
Closed
Offer information
Type Description
MER 1.17% (as at 28 Aug 2025)
Indirect Cost Ratio (ICR) 1.17% (as at 30 Jun 2025)
Performance fee (not included in ICR) Not Available
Minimum initial investment $5,000.00
Minimum additional investments
Minimum redemption amount

Top 10 holdings (as at 30 Jun 2025)

Holding (as at 30 Jun 2025) Type % of Portfolio
Eli Lilly and Co Equity 10.66%
Login now to view the complete list of holdings.

FAQs about the Colonial Wellington Global Health & Biotech

The objective of the Colonial Wellington Global Health & Biotech managed fund is To provide long-term capital growth by predominantly investing in companies around the world; whose primary business is in the fields of pharmaceuticals; biotechnology; healthcare services and medical products. The option aims to outperform the MSCI All Country Health Care Index over rolling three-year periods before fees and taxes.

The strategy of the Colonial Wellington Global Health & Biotech managed fund is The option's strategy is to add value by investing; over the medium to long term; in quality companies; with sustainable earnings per share growth and sensible valuations; whose primary business is healthcare related. The option does not hedge currency risk.

The APIR code of the Colonial Wellington Global Health & Biotech managed fund is FSF0146AU.

Colonial Wellington Global Health & Biotech’s total return last month was 6.96%. This was made up of a growth return of 6.96% and an income return of 0%. These returns were calculated as at 31 Oct 2025.

Colonial Wellington Global Health & Biotech’s total return for the last three months was 12.17%. This was made up of a growth return of 12.17% and an income return of 0%%. These returns were calculated as at 31 Oct 2025.

Colonial Wellington Global Health & Biotech’s one-year total return is -0.34%. This was made up of a growth return of -0.6% and an income return of 0.26%. These returns were calculated as at 31 Oct 2025.

Colonial Wellington Global Health & Biotech’s one-year total return is 4.17%. This was made up of a growth return of 4.08% and an income return of 0.09%. These returns were calculated as at 31 Oct 2025.

The asset allocation of the Colonial Wellington Global Health & Biotech managed fund is :

International Equities
95.68%
Cash
4.32%
Australian Equities
0%
Property & Infrastructure
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Colonial Wellington Global Health & Biotech managed fund is Colonial First State Investments Limited.

The Colonial Wellington Global Health & Biotech managed fund belongs to the Equity World Other sector/asset class.

As at 30 Sep 2025, the size of the Colonial Wellington Global Health & Biotech managed fund was $10.84 million.

The Colonial Wellington Global Health & Biotech managed fund has an inception date of 14 Apr 2000.

The current entry price of the Colonial Wellington Global Health & Biotech managed fund is $5.3933 per unit and the current exit price is $5.3879 per unit (as at 5 Nov 2025).

The current exit price of the Colonial Wellington Global Health & Biotech managed fund is $5.3879 per unit and the current entry price is $5.3933 per unit (as at 5 Nov 2025).

The minimum initial investment amount for the Colonial Wellington Global Health & Biotech managed fund is $5,000. Minimum additional investment is $0.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.